14
European Innovation Partnership on Active and Healthy Ageing Marianne van den Berg Innovation for Health and Consumers, DG SANCO 18 April 2012

European Innovation Partnership on Active and Healthy Ageing 18 April 2012. Source: SANCO, based on Ageing Report 2009 Life Expectancy (LE) 2008 -2060 LE vs. HLY (2010) Demographic

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

  • European Innovation Partnership on Active and Healthy Ageing

    Marianne van den Berg

    Innovation for Health and Consumers, DG SANCO

    18 April 2012

  • Source: SANCO, based on Ageing Report 2009

    LE vs. HLY (2010)LE vs. HLY (2010)Life Expectancy (LE) 2008Life Expectancy (LE) 2008--20602060

    Demographic projections 2008-2060

    177,3%

    2,0%

    86,4%

    0

    150

    300

    450

    600

    "+65" "+80" Total population

    popula

    tion in m

    io

    0%

    50%

    100%

    150%

    200%

    % c

    hange

    2008 2060 % change

    82,1

    76

    84,5

    89

    LE at birth women LE at birth men

    2008

    2060

    74,3

    60,161,3

    80,8

    Women Men

    HLY

    LE

  • Europe: Some facts and figures

    • Total health spending

    EU average of 9.6% of GDP in 2008

    • Total age-related spending: Education, pensions, healthcare, unemployment benefits

    Increase by 4.75% points of GDP by 2060

    • Shrinking workforce in the care sector and an insufficient number of health specialists

  • EIP on AHA: Objectives and headline target

    Headline target by 2020

    • Increasing the number of healthy life years (HLYs) by 2 in the EU on average

    A triple win for Europe

    • Enabling EU citizens to lead healthy, active and independent lives until old age

    • Improving the sustainability and efficiency of social and health care systems

    • Developing and deploying innovative solutions, thus fostering competitiveness and market growth

  • Collaborative innovation

    Bringing togetherinterested stakeholders from public and private sectors across the entire innovation value cycle

    To cooperate, share one same vision and aim to deliver innovative solutionsfor an ageing society,

    Responding to their needs and demands

  • EIP v&v EU existing funding tools

    Aligning Synergies Use efficiency Optimisation

    DuplicationOverlap

    Coordination

    Replacement

  • Public consultation

    • 524 submissions

    Steering Group Workshops

    • Mapping of research

    • Care&Cure

    • Prevention, early diagnosis

    • Active ageing & independent living

    Fiches with actions

    • 127 submissions

    Strategic

    Implementation Plan

    • Steering Group 7th of

    November 2011

    Three-step process stakeholder involvement

  • Prevention, screening & early diagnosis

    Care & Cure Active ageing & independent living

    •Health literacy, patient

    empowerment, ethics and adherence

    •Personal health

    management

    •Prevention, early

    diagnosis of functional and cognitive decline

    •Guidelines for care, workforce (multimorbidity,

    polypharmacy, frailty and collaborative care)

    •Multimorbidity and R&D

    •Capacity building and replicability of successful integrated care systems

    •Assisted daily living for older people with

    cognitive impairment

    •Flexible and interoperable ICT

    solutions for active and independent living

    •Innovation improving

    social inclusion of older people

    Vision / Foundation

    •Focus on holistic and multidisciplinary approach

    •Development of dynamic and sustainable care systems of tomorrow

    •New paradigm of ageing

    •Innovation in service of the elderly people

    •Regulatory and standardisation conditions

    •Effective funding

    •Evidence base, reference examples, repository for age-friendly innovation

    •Marketplace to facilitate cooperation among various stakeholders

    Horizontal issues

    Strategic Framework of the EIP on AHA

  • Criteria for ‘a priority action area’

    • Greatest contribution to the objectives of the partnership

    • Benefiting particularly from the partnershipapproach

    • Significantly contributing to overcoming key bottlenecks & barriers

    • Facilitating innovation in an area where European industry has or may develop a competitive advantage

    • Being the most ready to launch

  • • Prescription and adherence action at regional level.

    • Personalised health management, starting with a Fall Prevention Initiative

    • Action for prevention of functional decline and frailty with first action focused on physiological frailty and malnutrition

    • Replicating and tutoring integrated care for chronic diseases, including remote monitoring at regional level

    • Development of interoperable independent living solutions, including guidelines for business models

    • Thematic marketplace: innovation for age friendly buildings, cities and environments

  • Stakeholders’ involvement

    WHY GET INVOLVED?

    • Learn from the others’ good practice

    • Combine evidence

    • Collaboration leading to efficiency in (re-)design and validation of innovative care services

    • Efficiency of design leading to expansion of services to largerpopulation - with the same level of investment

    • Strengthen your ability to find funding at local/national level

    • Local industry seeing a larger market, beyond the “local border”

    • Political support

  • HO

    W T

    OEN

    GA

    GE

  • What can you expect from the Commission?

    • EIP monitoring and evaluation framework

    • Regulatory and standardization issues,

    • Alignment and effective use of EU funding instruments

    • Conference of Partners November 2012

  • Thank you for your attention

    https://webgate.ec.europa.eu/eipaha